PRAMA GCC Quality Conference

21 February 2025

Mövenpick Grand Al Bustan – Dubai, UAE

The GCC Quality Conference, is focused on the Commercial Quality Perspective and is the First Gathering Point for Commercial Quality Professionals in the GCC.

Regardless of the business, quality, is one of the most crucial management concepts for every firm.

This is especially true for the pharmaceutical industry, where upholding high product standards is crucial for the treatment and prevention of a wide range of diseases.

Overall, the GCC Quality Conference aims to foster a culture of quality excellence in the GCC region’s commercial sector.

Despite the fact that the pharmaceutical business has been operating for millennia, more pharmaceuticals have recently been introduced to the market. The demand for quality assurance and quality control procedures in the commercial state has increased as a result of this development.

Pharma QA and quality assurance departments are the backbones of the pharmaceutical business. They allow companies to guarantee that their products conform to applicable quality, drug stability and safety standards. In addition, they ensure that a company avoids non-compliance of regulatory requirements.

WHERE

Mövenpick Grand Al Bustan – Dubai, UAE

WHEN

21 February 2025

SPEAKERS

15+ Speakers

SEATS

100+ Seats

Gold Sponsor – AbbVie:

Mr. Amjad Matouk

Gold Sponsor – Takeda Pharmaceuticals:

Dr. Rasha Elbohi

Silver Sponsor – Bayer:

Dr. Hazem Asad

Why attend the GCC Quality Conference?

The GCC Quality Conference, which is the first meeting place for commercial quality professionals in the GCC, will be focused this year on the commercial quality perspective.

the GCC Quality Conference is specifically focusing on the commercial quality perspective. This means that the discussions, presentations, workshops, and panel sessions at the conference will center around various aspects of quality management within the commercial sector.

Commercial quality encompasses the processes, systems, and practices implemented by businesses to ensure that their products or services meet or exceed customer expectations and industry standards.

Individuals and organizations can enhance their understanding of quality requirements, procedures, and best practices, ultimately leading to improved quality outcomes and organizational success in the pharmaceutical sector.

OUR SPEAKERS 2024

View All Speakers

Attending the GCC Quality Conference offers numerous advantages for professionals in the pharmaceutical industry. By participating in this conference, you will:

Gain a broad understanding of quality measures
Stay informed about quality procedures and updates from industry & governmental speakers
Network with industry & GCC governmental professionals & share your expertise

Overall, attending the GCC Quality Conference in the pharmaceutical industry allows you to enhance your understanding of quality measures, stay updated with procedures and regulations, expand your professional network, and contribute to the industry’s knowledge sharing.

The GCC Quality Conference provides a valuable opportunity for individuals and organizations to enhance their understanding of the requirements and procedures necessary to effectively process and manage the quality department within their organization. Specifically, the conference aims to focus on the pharmaceutical industry and how organizations can excel in terms of quality management.

By attending the GCC Quality Conference, participants can expect to gain insights into various aspects of quality management in the pharmaceutical sector. This includes understanding the regulatory requirements and standards specific to the industry, as well as the best practices and strategies employed by successful organizations.

21 February 2025

Mövenpick Grand Al Bustan – Dubai, UAE

WHERE

WHEN

SPEAKERS

SEATS

Why attend the GCC Quality Conference?

OUR SPEAKERS 2024

Contact Us

Useful Links

Organized By

We accept

Why attend the GCC Quality Conference?

OUR SPEAKERS 2024

Position: Regulatory Affairs Pharmacist & GMP Auditor – Ministry of Health & Prevention (MoHAP)

Regulatory Affairs Pharmacist & GMP Auditor – Ministry of Health & Prevention (MoHAP)

Position: Senior Specialist Drugs Assessment - Department of Health, Abu Dhabi

Categories: Speakers 2024

Senior Specialist Drugs Assessment - Department of Health, Abu Dhabi

Position: QA Specialist at the General Administration of Quality Assurance – Egyptian Drug Authority (EDA)

Categories: Speakers 2024

Qualifications:

Master’s degree in Biochemistry from the Faculty of Science at Cairo University in 2019, where the thesis focused on evaluating the effectiveness of vaccines containing tetanus

Bachelor’s degree in Chemistry and Biochemistry from the Faculty of Science in

Certificates and Training:

Diploma in Total Quality Management from Brooklyn

Certified Project Management Professional (PMP) from the Project Management Institute (PMI).

Completed numerous trainings and workshops in various fields of the

Career Highlights:

Joined the National Organization for Research and Control of Biologicals in

Progressed in the National Organization for Research and Control of Biologicals in the Lot Release

Qualified for the position of Deputy Manager of the Lot Release Department in

Joined the Technical Office of the Central Administration for Biologicals, Clinical Studies, and Innovative Products from February 2019 to September

Qualified for the position of Manager of the Vaccines and Sera Lot Release Unit in

Assigned tasks as Quality Supervisor for Lot Release Management, in addition to her role as Manager of the Vaccines and Sera Release Unit in

In 2022, joined the General Administration of Quality Assurance as a Document Control Officer, then as a Risk Management Officer in 2023.

Assigned various other tasks within the administration such as Coordinator for the Institutional Excellence Award from the General Quality Management and Performance Indicators Monitor for the authority, and Coordinator for the Media office.

Contributions to Quality and Regulatory Systems and the achievements:

Contributed to the preparation of the Lot Release risk-based

Prepared all work procedures for Lot Release administration according to the new

Speaker at the first workshop held by the Egyptian Drug Authority in 2021 on Lot Release

Speaker at a workshop for Lot Release administration held by the Egyptian Drug Authority for companies on Product Quality Review (PQR).

Member of the WHO GBT for vaccines (Lot release function) task force as Unit Manager and Quality

Contributed to the preparation of the Egyptian Drug Policy and coordinated between various stakeholders and prepared the draft presented to the World Health

Member of the WHO GBT for pharmaceuticals (Regulatory system function) task

Member of the RCORE team on the Regulatory

Member of governance committees and monitoring committees for corrective actions within the

Prepared a file to qualify for the Best Team Award in one of the categories of the Egyptian Drug Authority’s competition in 2023 under the supervision of the General Manager of the General Administration of Quality Assurance and obtained first place in this

Member of the training team in the training program of the Yemeni High Authority for Medical Supplies on the topic:

Data Integrity and Good Documentation Practice: The Foundation of

Speaker at workshops and training sessions for General Quality Management to spread quality culture and increase awareness of the quality system in various topics:

QMS Documentation and Document Control: The Foundation of

Navigating Uncertainty: Effective Risk Management

Driving Success: Navigating Key Performance Indicators for Optimal

Awards and Honors:

Certificate of appreciation for dedicated efforts in achieving WHO GBT (Level 3 maturity) accreditation for vaccines in 2022.

The General Quality Assurance Management team won first place in the Best Team category in the Excellence Award competition from the Egyptian Drug Authority for

EDA HEROS Employee Excellence Award for their outstanding efforts, remarkable contributions, and positive impact in 2023.

Certificate of appreciation for tremendous efforts in implementing the new Integrated Quality Management System in 2023.

QA Specialist at the General Administration of Quality Assurance – Egyptian Drug Authority (EDA)

Position: Head of Quality Compliance, Audit and Technical Projects EME - Aspen Pharma

Categories: Speakers 2024

Head of Quality Compliance, Audit and Technical Projects EME - Aspen Pharma

Position: Distributor & Commercial Relation Manager - Bayer Middle East

Categories: Speakers 2024

Distributor & Commercial Relation Manager - Bayer Middle East

Position: Quality Assurance Manager, Gulf-Levant – AbbVie

Categories: Speakers 2024

Quality Assurance Manager, Gulf-Levant – AbbVie

Position: Head of Quality - Bayer Middle East

Categories: Board Members 2024

Head of Quality - Bayer Middle East

Position: Middle East Quality Lead - Takeda Pharmaceuticals

Categories: Board Members 2024

Middle East Quality Lead - Takeda Pharmaceuticals

Position: Regional LOC Quality Executive (Gulf, Near East, & Saudi Arabia) – Haleon

Categories: Speakers 2024

Regional LOC Quality Executive (Gulf, Near East, & Saudi Arabia) – Haleon

Contact Us

Useful Links

Social Networks

Organized By

We accept